.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Colorcon
AstraZeneca
Chubb
Daiichi Sankyo
Deloitte
Covington
Healthtrust
Federal Trade Commission
Cantor Fitzgerald

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064096

« Back to Dashboard
NDA 064096 describes AKTOB, which is a drug marketed by Akorn and is included in one NDA. It is available from six suppliers. Additional details are available on the AKTOB profile page.

The generic ingredient in AKTOB is tobramycin. There are eighteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tobramycin profile page.

Summary for NDA: 064096

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 064096

Ingredient-typeAminoglycosides

Suppliers and Packaging for NDA: 064096

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AKTOB
tobramycin
 SOLUTION/DROPS;OPHTHALMIC 064096 ANDA Henry Schein Inc. 0404-7196 0404-7196-01 1 BOTTLE, DROPPER in 1 CARTON (0404-7196-01) > 5 mL in 1 BOTTLE, DROPPER
AKTOB
tobramycin
 SOLUTION/DROPS;OPHTHALMIC 064096 ANDA Blenheim Pharmacal, Inc. 10544-883 10544-883-99 1 BOTTLE, DROPPER in 1 CARTON (10544-883-99) > 5 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.3%
Approval Date:Jan 31, 1996TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Queensland Health
Chinese Patent Office
Julphar
McKesson
UBS
Harvard Business School
Express Scripts
Daiichi Sankyo
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot